{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:59:35Z","timestamp":1792699175870,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00384-020-03731-7","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T16:03:46Z","timestamp":1598630626000},"page":"2323-2329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors of chemotherapy-induced nausea and vomiting in patients with metastatic colorectal cancer: a prospective cohort study (YCOG1301)"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-8383","authenticated-orcid":false,"given":"Shogo","family":"Takei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3251-3658","authenticated-orcid":false,"given":"Atsushi","family":"Ishibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuteru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Kunisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"issue":"5","key":"3731_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/bf00434947","volume":"1","author":"CM Lindley","year":"1992","unstructured":"Lindley CM, Hirsch JD, O\u2019Neill CV, Transau MC, Gilbert CS, Osterhaus JT (1992) Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1(5):331\u2013340. https:\/\/doi.org\/10.1007\/bf00434947","journal-title":"Qual Life Res"},{"issue":"9","key":"3731_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jjco\/hyg083","volume":"33","author":"S Morita","year":"2003","unstructured":"Morita S, Kobayashi K, Eguchi K, Matsumoto T, Shibuya M, Yamaji Y, Sakamoto J, Ohashi Y (2003) Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model. Jpn J Clin Oncol 33(9):470\u2013476. https:\/\/doi.org\/10.1093\/jjco\/hyg083","journal-title":"Jpn J Clin Oncol"},{"issue":"19","key":"3731_CR3","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1200\/JCO.2000.18.19.3409","volume":"18","author":"JP Ioannidis","year":"2000","unstructured":"Ioannidis JP, Hesketh PJ, Lau J (2000) Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence. J Clin Oncol 18(19):3409\u20133422","journal-title":"J Clin Oncol"},{"issue":"28","key":"3731_CR4","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/jco.2017.74.4789","volume":"35","author":"PJ Hesketh","year":"2017","unstructured":"Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH (2017) Antiemetics: American Society of Clinical Oncology Clinical Practice guideline update. J Clin Oncol 35(28):3240\u20133261. https:\/\/doi.org\/10.1200\/jco.2017.74.4789","journal-title":"J Clin Oncol"},{"key":"3731_CR5","unstructured":"NCCN Clinical Practice Guidelines in Oncology-Antiemesis- (2019) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf."},{"key":"3731_CR6","unstructured":"Oncology JSoC (2015) Guidelines for appropriate use of antiemetic drugs, Version 2. Kanehara Tokyo,"},{"issue":"suppl_5","key":"3731_CR7","doi-asserted-by":"publisher","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","volume":"27","author":"F Roila","year":"2016","unstructured":"Roila F, Copenhagen obotpotMECC, Molassiotis A, Copenhagen obotpot MECC, Herrstedt J, Copenhagen obotpotMECC, Aapro M, Copenhagen obotpotMECC, Gralla RJ, Copenhagen obotpotMECC, Bruera E, Copenhagen obotpotMECC, Clark-Snow RA, Copenhagen obotpotMECC, Dupuis LL, Copenhagen obotpotMECC, Einhorn LH, Copenhagen obotpotMECC, Feyer P, Copenhagen obotpotMECC, Hesketh PJ, Copenhagen obotpotMECC, Jordan K, Copenhagen obotpotMECC, Olver I, Copenhagen obotpotMECC, Rapoport BL, Copenhagen obotpotMECC, Roscoe J, Copenhagen obotpotMECC, Ruhlmann CH, Copenhagen obotpotMECC, Walsh D, Copenhagen obotpotMECC, Warr D, Copenhagen obotpotMECC, van der Wetering M, Copenhagen obotpotMECC (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 27(suppl_5):v119\u2013v133. https:\/\/doi.org\/10.1093\/annonc\/mdw270","journal-title":"Ann Oncol"},{"key":"3731_CR8","unstructured":"NCCN Clinical Practice Guidelines in Oncology-Colon Cancer- (2019) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf. Accessed Jun 24 2019"},{"key":"3731_CR9","unstructured":"NCCN Clinical Practice Guidelines in Oncology-Rectal Cancer- (2019) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/rectal.pdf. Accessed Jun 24 2019"},{"issue":"5","key":"3731_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","volume":"20","author":"K Tamura","year":"2015","unstructured":"Tamura K, Aiba K, Saeki T, Nakanishi Y, Kamura T, Baba H, Yoshida K, Yamamoto N, Kitagawa Y, Maehara Y, Shimokawa M, Hirata K, Kitajima M, Japan CSGo (2015) Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol 20(5):855\u2013865. https:\/\/doi.org\/10.1007\/s10147-015-0786-7","journal-title":"Int J Clin Oncol"},{"key":"3731_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejphar.2013.10.015","volume":"722","author":"D Warr","year":"2014","unstructured":"Warr D (2014) Prognostic factors for chemotherapy induced nausea and vomiting. Eur J Pharmacol 722:192\u2013196. https:\/\/doi.org\/10.1016\/j.ejphar.2013.10.015","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3731_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10147-016-1022-9","volume":"22","author":"H Takemoto","year":"2017","unstructured":"Takemoto H, Nishimura J, Komori T, Kim HM, Ota H, Suzuki R, Ikenaga M, Ikeda M, Yamamoto H, Satoh T (2017) Combination antiemetic therapy with aprepitant\/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea. Int J Clin Oncol 22(1):88\u201395","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"3731_CR13","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.21873\/anticanres.13596","volume":"39","author":"M Hayashi","year":"2019","unstructured":"Hayashi M, Nakazawa K, Hasegawa Y, Horiguchi J, Miura D, Ishikawa T, Takao S, Kim SJ, Yamagami K, Miyashita M, Konishi M, Shigeoka Y, Suzuki M, Taguchi T, Kubota T, Tanino H, Yamada K, Narui K, Kimura K, Akazawa K, Kohno N, Group JS (2019) Risk analysis for chemotherapy-induced nausea and vomiting (CINV) in patients receiving FEC100 treatment. Anticancer Res 39(8):4305\u20134314. https:\/\/doi.org\/10.21873\/anticanres.13596","journal-title":"Anticancer Res"},{"issue":"1","key":"3731_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1200\/jco.1997.15.1.116","volume":"15","author":"D Osoba","year":"1997","unstructured":"Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L (1997) Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 15(1):116\u2013123. https:\/\/doi.org\/10.1200\/jco.1997.15.1.116","journal-title":"J Clin Oncol"},{"issue":"6","key":"3731_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/cas.12146","volume":"104","author":"I Sekine","year":"2013","unstructured":"Sekine I, Segawa Y, Kubota K, Saeki T (2013) Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis. Cancer Sci 104(6):711\u2013717. https:\/\/doi.org\/10.1111\/cas.12146","journal-title":"Cancer Sci"},{"issue":"6","key":"3731_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00520-010-0899-5","volume":"19","author":"DG Warr","year":"2011","unstructured":"Warr DG, Street JC, Carides AD (2011) Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin\u2013cyclophosphamide-based chemotherapy. Support Care Cancer 19(6):807\u2013813. https:\/\/doi.org\/10.1007\/s00520-010-0899-5","journal-title":"Support Care Cancer"},{"issue":"6","key":"3731_CR17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","volume":"28","author":"G Dranitsaris","year":"2017","unstructured":"Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, Jordan K, Young A, Aapro M (2017) The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting. Ann Oncol 28(6):1260\u20131267. https:\/\/doi.org\/10.1093\/annonc\/mdx100","journal-title":"Ann Oncol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-020-03731-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T23:45:39Z","timestamp":1630107939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-020-03731-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3731"],"URL":"https:\/\/doi.org\/10.1007\/s00384-020-03731-7","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"25 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Yokohama City University (No. D1304001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}